Astek Diagnostics, a Baltimore, MD-based developer of an urine-based diagnostic instrument, acquired a Pre-Sequence A funding from She’s Unbiased.
Different traders included embrace Y Combinator, AYANA Capital, Wexford Scitech Enterprise Fund, Harvard Administration Seed Capital, TEDCO, Maryland Momentum Fund, Goldin Ventures, Maryland Know-how Growth Company, Maryland Innovation Initiative, Maryland Industrial Partnerships, Key Applied sciences, Abell Basis, and outstanding angel traders. Astek has additionally acquired funding from the Nationwide Science Basis, the Meals and Drug Administration, the Biomedical Superior Analysis and Growth Authority, the Nationwide Institute of Well being, and others.
The quantity of the deal was not disclosed.
The corporate intends to make use of the funds to develop operations and its enterprise attain.
Led by CEO Mustafa Al-Adhami, Astek is the developer of Jiddu™ Analyzer, an urine-based diagnostic instrument. The corporate is actively working towards FDA advertising authorization utility approval and has initiated collaborations with three impartial urology clinics to exhibit the feasibility of the Jiddu Analyzer in small medical research utilizing actual urine specimens. Astek not too long ago initiated an early entry program targeted on urology clinics and hospitals with a view to deploy the Jiddu Analyzer alpha prototype by mid-2024 in choose areas.
FinSMEs
06/04/2024
